This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Pure Red Cell Aplasia Market

Market Insights on Pure Red Cell Aplasia covering sales outlook, demand forecast & up-to-date key trends

Pure Red Cell Aplasia Market:Global Industry Analysis 2015 - 2019 and Opportunity Assessment 2020 - 2030

Pure Red Cell Aplasia Market Overview

Pure red cell aplasia is a type of rare disorder related to the production of blood in the body. Spongy tissue between bone marrow fails to produce sufficient blood for the body leading to anaemic conditions. In pure red cell aplasia, only red blood cells of the blood are affected, whereas white blood cells are at normal levels.

Red blood cells play a key role in carrying oxygen in the body. Pure red cell aplasia leads to increased heart rate, decrease in physical activity and pale appearance. Pure red cell aplasia can be acquired or genetic. According to the National Organization of Rare Disorders, globally there are approximately 5000 active cases of Diamond Blackfan Anaemia which is inherited pure red cell aplasia.

Due to the Covid-19 pandemic, the lockdown has been implemented in several countries leading to delay of manufacturing activities and disruption of supply chain impacting pure red cell aplasia market. There has been a significant decline in hospital visits and treatment adoption amid pandemic delaying the growth of pure red cell aplasia market.

There has been a shift of focus of leading biopharmaceuticals towards developing coronavirus cure, hence delay in research and development activities of pure red cell aplasia market.

Unmet need of the therapy and rise in prevalence of rare anaemic disorders increases the demand for pure red cell aplasia market. Increasing collaborative research and development activities among leading biopharmaceutical innovative players are expected to fuel the growth of pure red cell aplasia market.

For instance, in March 2018 Novartis AG’s New Drug Application was accepted by U.S. Food and Drug Administration and granted priority review designation for its drug used in first-line treatment of pure red cell aplasia. Advancement in technology creates therapeutic options and hence propel pure red cell aplasia market growth. The stringent regulatory requirement for drug approval is challenging pure red cell aplasia market growth.

Immunosuppressant holds a major revenue share of pure red cell aplasia market. Whereas, the corticosteroid is expected to observe significant growth with increased demand in pure red cell aplasia market. Oral route of administration is most common in pure red cell aplasia market.

The intravenous route of administration also holds significant share for cell transfusion in pure red cell aplasia market. Hospital pharmacies is the largest distribution channel in pure red cell aplasia market with the high patient population. On the other hand, online pharmacies segment is expected to observe an exponential rise in pure red cell aplasia market with increased penetration of e-commerce in the market.

North America will continue to dominate the pure red cell aplasia market in the coming decade with a high rate of approvals and commercialization of pharmaceutical drugs. The high rate of prevalence of anaemia increases the demand for pure red cell aplasia market in North America.

Europe is the second leading region in pure red cell aplasia market with advanced diagnostic and treatment technology. Asia-pacific is lucrative with a higher growth rate in the pure red cell aplasia market during the forecast period with increasing domestic players in the region. Poor economic conditions in the Middle East and Africa make them untapped regions with fewer growth opportunities for pure red cell aplasia market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Some key players contributing in pure red cell aplasia market are

  • F. Hoffmann-La Roche AG
  • Bayer AG
  • Novartis AG
  • Johnson & Johnson
  • Pfizer Inc.
  • Merck & Co.Inc.
  • Bristol Myers Squibb Company
  • Amgen Inc.
  • AbbVie Pharmaceuticals
  • Eli Lilly and Company
  • Alexion Pharmaceuticals Inc.
  • GlaxoSmithKline plc.
  • Seattle Genetics
  • Sanofi S.A.
  • Biogen Inc.
  • AstraZeneca PLC
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

The report on pure red cell aplasia market covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Historical Actual Market Size, 2015 - 2019
  • Market Size & Forecast 2020 to 2030
  • Supply & Demand Value Chain
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
  • Market Drivers and Restraints

Regional analysis for pure red cell aplasia market includes

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Pure Red Cell Aplasia Market: Segmentation

The global pure red cell aplasia market is classified based on catheter type, application, gender, end-users and region.

Drug Type

  • Corticosteroids 
  • Immunosuppressant
  • Anti-inflammatory Biologics
  • Non-Steroidal Anti-inflammatory Drugs (NSAIDs) 

Route of Administration

  • Oral 
  • Intravenous 

Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Drug stores
  • Online pharmacies
Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Pure Red Cell Aplasia Market